Bengbu Fengyuan Pharmaceutical Technology Development Co., Ltd.
Published:
2018-08-07
Source:
Author:
Bengbu Fengyuan Pharmaceutical Technology Development Co., Ltd. was established in December 2000. It is a pharmaceutical engineering laboratory in Anhui Province and a new R&D institution in Anhui Province. The company is mainly engaged in the development of new drugs, generic drugs, pharmaceutical intermediates, and pharmaceutical excipients. The company has successively developed and listed Leluoer (Nafidil Tablets), Zaleplon Tablets, Zhixin (Cilnidipine Tablets), Lebixin (Diclofenac Sodium Patches), Lebuquer (Diclofenac Sodium Patch) for Fengyuan Pharmaceutical. Paracetamol and pseudomacrotine tablets), Pulicang (fructose injection) and other new drugs in many countries.
The company attaches great importance to industry-university-research cooperation, and cooperates with University of Science and Technology of China, Fudan University, Beijing Institute of Technology, China Pharmaceutical University, Second Military Medical University, China Pharmaceutical University, Hefei University of Technology and other universities in project cooperation and personnel training. A close partnership has been established. Every year, master and undergraduate students from many universities conduct research in the company, which is an internship base for students from many universities; the company also cooperates with Institute of Materia Medica, Chinese Academy of Medical Sciences, Shanghai Institute of Pharmaceutical Industry, Tianjin Pharmaceuticals Research institutes such as the Research Institute and the Institute of Microbiology of the Chinese Academy of Sciences have established close contacts and communicated extensively.
The company has established a complete R&D quality system, and has accumulated rich experience in the fields of local anesthesia injection, eye drops, API registration and filing research, etc., and hopes to cooperate with colleagues in the pharmaceutical industry to create the future of China's pharmaceutical industry .
Related Information
2022-06-30

2022-06-30

2022-06-30
